SCHEMBL7560746

SCHEMBL7560746

Cc1ccc(NC2=CC(=O)SC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.43
TDP1 Q9NUW8 2/20 0.43
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
LMNA P02545 4/20 0.42
KMT2A Q03164 4/20 0.42
TP53 P04637 3/20 0.42
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
PKM P14618 1/20 0.42
POLB P06746 2/20 0.41
HPGD P15428 2/20 0.39
MAPK1 P28482 2/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
BLM P54132 2/20 0.38
HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522548 0.82 MT-CO2 (0.51) KDM4ESMN1; SMN2NPC1RAB9ALMNA
SCHEMBL7559674 0.81 SMN1; SMN2 (0.44) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL8210609 0.79 RAB9A (0.50) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL7528545 0.68 KDM4E (0.58) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL108881 0.66 HPGD (0.78) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL9516537 0.66 HPGD (0.78) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL50079 0.66 HPGD (0.78) KDM4ESMN1; SMN2TDP1NPC1RAB9A
Water SCHEMBL8602751 0.63 HPGD (0.74) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL19675165 0.62 HPGD (0.45) KDM4ESMN1; SMN2TDP1NPC1RAB9A
SCHEMBL1921510 0.60 HPGD (0.67) SMN1; SMN2TDP1NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed